-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Spotlight Sessions

Sunday, December 10, 2023

Sunday | Monday | top

4:30 PM-5:45 PM

Debate: PCC or Andexanet alfa for Managing Bleeding in Patients on Oral Xa Inhibitors?
Immunometabolism as a Tool to Advance Cell Therapy
Tackling Greater Burden of Multiple Myeloma in African American Patients.
Where the Bench Meets the Bedside: Laboratory Correlates in Clinical Trials

Monday, December 11, 2023

Sunday | Monday | top

10:30 AM-11:45 AM

Advances in Genomics: Tools Finally Opening the Molecular Secrets of Burkitt Lymphoma

2:45 PM-4:00 PM

Factor XI - From Bleeding to Thrombosis
Managing Previvorship in Hematology: Clinical Approaches to CCUS and MBL
What is a “Normal” Neutrophil Count? The Duffy Red Cell Antigen, Ancestry, Genetics and Evolution
Who are the Alternatives for Cellular Therapies? Engineering and Retargeting Other Effector Lymphocytes